Miracle Mile Advisors’s Novo Nordisk NVO Stock Holding History

Miracle Mile Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$528K	Buy	11,005 +2,170	+25%	+$93.2K	0.01%	610
2026 Q1	$325K	Sell	8,835 -223	-2%	-$10.6K	﹤0.01%	706
2025 Q4	$461K	Sell	9,058 -605	-6%	-$30.9K	0.01%	592
2025 Q3	$536K	Buy	9,663 +2,406	+33%	+$141K	0.01%	536
2025 Q2	$501K	Buy	7,257 +3,255	+81%	+$221K	0.01%	480
2025 Q1	$278K	Buy	+4,002	New	+$331K	0.01%	540
2024 Q4	–	Sell	-3,191	Closed	-$380K	–	656
2024 Q3	$380K	Sell	3,191 -2,329	-42%	-$311K	0.01%	387
2024 Q2	$788K	Buy	5,520 +519	+10%	+$68.8K	0.02%	292
2024 Q1	$642K	Buy	5,001 +649	+15%	+$77.3K	0.02%	321
2023 Q4	$450K	Buy	4,352 +1,006	+30%	+$99.5K	0.01%	350
2023 Q3	$304K	Hold	3,346	–	–	0.01%	399
2023 Q2	$271K	Buy	+3,346	New	+$273K	0.01%	433

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Miracle Mile Advisors's NVO Position: Q2 2026 in Review

Miracle Mile Advisors increased its Novo Nordisk (NVO) stake by 25% in Q2 2026, buying an estimated $93.2K and bringing the position to 11,005 shares worth $528K. The position accounts for 0.01% of the portfolio, ranked #610.

Miracle Mile Advisors first reported a position in NVO in Q2 2023 and has held it in 12 quarters since. The position peaked at $788K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Miracle Mile Advisors held 11,005 shares of Novo Nordisk worth $528K as of Q2 2026.
Miracle Mile Advisors bought 2,170 Novo Nordisk shares in Q2 2026, an estimated $93.2K.
Novo Nordisk made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #610 holding.
Miracle Mile Advisors first reported a position in Novo Nordisk in Q2 2023 and has held it in 12 quarters since.
Miracle Mile Advisors's Novo Nordisk position peaked at $788K in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.